YUVEZZI Archives - PharmaDeviceNews

Can Tenpoint Therapeutics’ direct-to-patient YUVEZZI program unlock wider access in the presbyopia market?

By Pallavi Madhiraju on April 4, 2026 Pharma & Biotech

Tenpoint Therapeutics and PHIL launch YUVEZZI direct-to-patient access for presbyopia. Read what it means for affordability, uptake, and market adoption.

Tenpoint’s YUVEZZI sets new benchmark in presbyopia eye drop efficacy and safety

By Pallavi Madhiraju on January 30, 2026 Pharma & Biotech

YUVEZZI becomes the first FDA-approved dual-agent eye drop for presbyopia. Find out what this means for Tenpoint Therapeutics and the future of vision care.